Introduction: Cognitive dysfunction has been significantly associated with func-
| Patients
Patients from the University Malaya Medical Centre, Kuala Lumpur, Malaysia, who were aged between 21 and 65 years old and diagnosed with an active episode of MDD during the study visit were enrolled in the study. Key exclusion criteria included current diagnosis or past medical history of schizophrenia or other psychotic disorders, bipolar disorder, dementia or other neurodegenerative disease, alcohol or substance use dependence, or other psychiatric disorder, or previous enrollment in the present study or in a clinical trial.
| Study assessments
In the CogDAD study, patients were assessed by physicians and completed patient-reported outcome questionnaires during a single study visit.
Depression severity was assessed by physicians using the Clinical Global Impressions Severity of illness scale (CGI-S); a standardized 7-point scale that provides a global assessment of the patient's severity of symptoms: A score of 1 indicates that the patient is of normal health, and a score of 7 indicates that the patient is extremely ill (Busner & Targum, 2007; Spearing, Post, Leverich, Brandt, & Nolen, 1997) .
Depression severity was assessed by patients using the 9-item Patient Health Questionnaire (PHQ-9), in which they indicated the degree to which each of the nine depressive symptoms (corresponding to the criteria in the Diagnostic and Statistical Manual of Mental Disorders 4th edition) had bothered them in the past 2 weeks (Martin, Rief, Klaiberg, & Braehler, 2006) . Each item could be scored from 0
("not at all") to 3 ("nearly every day") (Kroenke & Spitzer, 2002) .
Depression severity was then calculated based on the sum of individual scores (Martin et al., 2006) . The PHQ-9 scores were categorized as follows: "no depression" (1-4), "mild depression" (5-9), "moderate depression" (10-14), "moderately severe depression" (15-19), and "severe depression" (20-27) (Kroenke & Spitzer, 2002) . Of note, patients who had rated ≥1 on any of the PHQ-9 items were also asked to rate how difficult the symptoms had made it for them to work, take care of things at home, or get along with other people, which could be rated as "not difficult at all" (1), "very difficult" (2), or "extremely difficult" (3) (Kroenke & Spitzer, 2002) .
Patients also performed a self-assessment of their cognitive dysfunction using the Perceived Deficits Questionnaire (PDQ-D), which consists of 20 items constructing four domains of cognitive function: "Attention/Concentration," "Retrospective Memory," "Prospective Memory," and "Organization/Planning" (Kim et al., 2016) .
Patients scored each PDQ-D item according to how frequently they experienced a cognitive symptom in the past 7 days: 0 ("never"), 1 ("rare"), 2 ("sometimes"), 3 ("often"), 4 ("very often"). The score for each subscale could range from 0 to 20. The PDQ-D Total Score was the sum of all four subscale scores and could range from 0 to 80. Patients who scored ≥1 for each of the 20 PDQ-D items received a total PDQ-D score ≥20, which was the cutoff score for clinically relevant cognitive dysfunction in this study. Since the severity of perceived cognitive dysfunction is not defined by cutoff scores, it was described in terms of distribution-based quartiles in this study;
higher scores indicate more severe perceived cognitive dysfunction.
The Sheehan Disability Scale (SDS) was used by patients to assess their functional disability in the domains of "Work/School," "Social Life/Leisure Activities,", and "Family Life/Home Duties." Patients rated the severity of functional disability in each domain in the past 7 days on a 10-point scale. An SDS domain score ≥4 indicated moderate, marked, or extreme functional disability. A total score of functional disability, ranging from 0 (no functional disability) to 30 (severe functional disability), was computed by summing the domain scores.
The total score was only computed for patients who worked or studied in the past week.
Socio-demographic data and medical history, including MDD history and management, were also collected during the study visit.
There were no specific safety assessments beyond the routine reporting of adverse events.
| Subgroup statistical analyses
The present subgroup analysis was conducted on all eligible Malaysian patients from the CogDAD study who provided informed consent, met the selection criteria, and completed at least one patient-reported outcome questionnaire.
Descriptive statistics were used to summarize data on patient demographics and study assessments. Unless otherwise specified, continuous variables were shown as frequency of observations and mean ± standard deviation (SD), whereas categorical and binary variables were shown as counts and percentages. Statistical tests were two-tailed, with statistical significance set at P < 0.05.
Univariate and multivariate analyses were used to identify factors associated with functional disability in Malaysian patients in the CogDAD study. Total SDS score and SDS domain scores were first compared between patient subgroups using one-way analyses of variance (ANOVAs). Analyses of covariance (ANCOVAs) were subsequently performed to determine whether factors associated with the total SDS score and individual SDS domain scores in the univariate analysis (P < 0.05 in ANOVA) had any statistically significant effect on the total SDS score and individual SDS domain scores, when correcting for PHQ-9.
Results of the Malaysian subgroup analysis were compared with the overall CogDAD population using descriptive analyses, including the patient demographics and assessment scores.
For all outcomes presented herein, missing data were not replaced in the analyses. Analyses were performed using the SPSS statistical software (SAS Institute, Cary, NC, USA), Version 20.0.0.
| RESULTS
All 211 patients from Malaysia enrolled in the CogDAD study were included in this subgroup analysis.
| Patient demographics
Patient demographics are shown in Table 1 . Malaysian patients had a mean age of 45.2 ± 12.4 years. The majority of patients were women (56.9%), married or living as a couple (59.2%), and living in the city (97.2%). Most patients (81.5%) were working, students, or homemakers.
| Depression severity, MDD history, and MDD management
At the time of the study visit, 75.8% of patients had been experiencing the current depressive episode for more than 8 weeks. Patients reported a mean total PHQ-9 score of 9.76 ± 6.23 (moderate depression) and were assessed by physicians to have a mean CGI-S score of 3.53 ± 0.83 (mild to moderate depression). Approximately half of the patients (47.9%) were experiencing their first depressive episode during the study visit, while the remaining 52.1% had a history of depressive episodes. The majority of patients with a history of depressive episodes (88.2%) had experienced two or more previous depressive episodes, with almost half the patients (44.5%) experiencing their last depressive episode more than 12 months prior to the onset of the current depressive episode.
In terms of MDD management, most patients (79.6%) were already undergoing at least one pharmacological or nonpharmacological treatment for the current depressive episode. Additionally, most patients were treated with antidepressants in their last depressive episode (90.9%) and achieved clinical remission following the episode (82.7%).
| Severity of cognitive dysfunction and functional disability
Outcome scores are presented in Table 2 Patients reported a mean total SDS score of 11.47 ± 6.68 and experienced mild disruption (SDS score ≤ 4) in the SDS domains of "Work/School Work" (3.83 ± 2.38), "Social Life/Leisure Activities" (4.02 ± 0.17) and "Family Life/Home Responsibilities" (3.85 ± 2.52).
On average, patients reported 1.40 ± 2.36 days lost (absenteeism) and 2.01 ± 2.61 unproductive days (presenteeism) in the last 7 days due to MDD.
| Comparison with the overall Asian population in the CogDAD study
Malaysian patients were generally similar to the overall study population in terms of marital and work status. The Malaysian patient population had a greater proportion of males than the overall CogDAD study population. Moreover, a higher percentage of Malaysian patients resided in the city as compared with the overall population (Table 1) .
Compared with the overall study population, a higher proportion of Malaysian patients experienced the current depressive episode for less than a week, and a lower proportion of Malaysian patients experienced the current depressive episode for more than 8 weeks.
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The majority of patients (35.1%) in the overall study population had one prior depressive episode, whereas the majority of Malaysian patients (34.5%) had two prior depressive episodes. A higher proportion of Malaysian patients (44.5%) experienced their last depressive Patients with a previous depressive episode. d Patients who discontinued treatment 2 weeks before the current study visit.
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Malaysian patients displayed similar CGI-S, PDQ-D, and SDS scores to those of the overall study population (Table 2) . Malaysian patients had a mean CGI-S score of 3.53 ± 0.83, which was comparable with that of the overall population (3.28 ± 0.99). Malaysian patients had a mean PHQ-9 score of 9.76 ± 6.23, which was slightly lower than that of the overall population (11.27 ± 6.92). Functional disability, as assessed by SDS scores, was comparable in both populations, with similar absenteeism (days lost in the last 7 days) and presenteeism (unproductive days in the last 7 days). Cognitive function, as assessed by PDQ-D scores, was also comparable in both populations. The most affected domain of perceived cognitive dysfunction was attention/concentration, followed by planning/organization, retrospective, and prospective memory.
| Factors associated with functional disability
In order to identify factors associated with functional disability, ANCOVA models were established for all SDS domains (Table 3) . Total PDQ-D score, sick leave, and antidepressant treatment were independently associated with total functional disability (P < 0.05). In addition, PDQ-D score was independently associated with the two SDS domains of "Work/School Work" and "Family Life/Home Activities." Excludes patients who had not worked/studied in the past week (n = 66).
b Excludes patients who had not worked/studied in the past week (n = 31).
c
Excludes patients who had not answered (n = 72) and patients who had not worked/studied in the past week (n = 66). impact workplace productivity, and other domains such as "Attention/Concentration" could have a greater effect on a family setting.
In addition to cognitive dysfunction, findings from our subgroup analysis showed that functional disability was significantly associated with sick leave and antidepressant treatment. Absenteeism and receiving antidepressant treatment may also possibly reflect depression severity, as patients with severe depression are more likely to incur sick days and receive antidepressant treatment. In addition, some antidepressants may incur side effects that could impact functionality.
Two main limitations apply to this subgroup analysis. Firstly, the CogDAD study was a cross-sectional study; hence, no definite conclusions could be drawn about the causal relationships observed between perceived cognitive dysfunction, depression severity, and functional disability. Secondly, this analysis comprised mainly Malaysian patients with mild-to-moderate MDD who lived in the city. As such, the results of our study may not be generalizable to Malaysian patients living in rural areas or whom are diagnosed with severe MDD.
| CONCLUSION
Malaysian patients with MDD suffer from cognitive impairment, which is strongly associated with significant functional disability, particularly in their social lives and leisure activities. Our findings suggest that MDD could be better managed with regular cognitive function assessments due to its impact on daily functioning in the clinical setting in an Asian Malaysian population.
